Key Features & Benefits: Rapid Results: Obtain clear, qualitative results in 10-15 minutes, enabling immediate counseling and timely clinical decision-making. Exceptional Accuracy: Demonstrates 98.9% agreement with hemoglobin electrophoresis (REF method) in clinical studies, ensuring high confidence in results. Comprehensive Detection: Identifies the presence of Hemoglobin variants A, S, and C, aiding in the diagnosis of: Sickle Cell Trait (HbAS),Sickle Cell Disease (HbSS),Sickle-Hb C Disease (HbSC)
Sickle-Hb C Trait (HbAC),Normal (HbAA) Simple & User-Friendly: The intuitive process requires minimal training. The kit includes everything needed: test cassette, pre-measured buffer, sampler, and clear instructions. Dual Sample Compatibility: Validated for use with both fingerstick capillary blood and K2EDTA venous whole blood, offering flexibility in any clinical setting. Built-In Quality Control: A procedural control line ensures every test is valid and the result is reliable. Room Temperature Stable: The kit is stable for 24 months at 2°C – 30°C (35°F – 86°F), requiring no refrigeration, simplifying storage and logistics. Intended Use:
This kit is for the qualitative in vitro diagnostic detection of hemoglobin variants A, S, and C in human capillary or venous whole blood. It is intended for use by healthcare professionals to aid in the rapid diagnosis of sickle cell disorders.
Kit Contents:
Test Cassettes (individually foil-packed with desiccant)
Buffer Solution
Blood Samplers
Comprehensive Instructions for Use (IFU)
Available Packaging Options:
To suit the needs of any practice size, the kit is available in multiple box sizes:
1 test/box
10 tests/box
20 tests/box
25 tests/box
50 tests/box
100 tests/box
Empower Your Practice with Rapid Diagnostics.
Early diagnosis of sickle cell disease is critical for initiating life-saving therapies, including penicillin prophylaxis, vaccinations, and patient education. This rapid test kit is an essential tool for improving access to timely diagnosis and genetic counseling, ultimately enhancing the standard of care for patients and families affected by sickle cell conditions.
The Sickle Cell Disease Rapid Test Kit (GICA) is a state-of-the-art, qualitative lateral flow immunoassay designed for the rapid and reliable detection of key hemoglobin variants A, S, and C. This innovative test empowers healthcare professionals—from doctors and nurses to lab technicians—to obtain critical diagnostic information at the point of care, facilitating early intervention and improved patient outcomes.
Using a simple fingerstick or venipuncture whole blood sample, this CLSI-validated kit delivers clear, easy-to-interpret results in 10-15 minutes, eliminating the long wait times associated with traditional lab-based methods like electrophoresis.
